Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination
The SARS-CoV-2 Omicron variant BA.2 sublineage is rapidly replacing earlier Omicron lineages, suggesting BA.2 has increased vaccine evasion properties. We measured neutralization titers of authentic BA.1 and BA.2 isolates in serum samples from persons who received the BNT162b2 booster vaccine. All...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2022-06-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/28/6/22-0503_article |
_version_ | 1811247138906046464 |
---|---|
author | Rune M. Pedersen Line L. Bang Lone W. Madsen Thomas V. Sydenham Isik S. Johansen Thøger G. Jensen Ulrik S. Justesen Thomas E. Andersen |
author_facet | Rune M. Pedersen Line L. Bang Lone W. Madsen Thomas V. Sydenham Isik S. Johansen Thøger G. Jensen Ulrik S. Justesen Thomas E. Andersen |
author_sort | Rune M. Pedersen |
collection | DOAJ |
description |
The SARS-CoV-2 Omicron variant BA.2 sublineage is rapidly replacing earlier Omicron lineages, suggesting BA.2 has increased vaccine evasion properties. We measured neutralization titers of authentic BA.1 and BA.2 isolates in serum samples from persons who received the BNT162b2 booster vaccine. All samples neutralized BA.1 and BA.2 at equal median values.
|
first_indexed | 2024-04-12T15:03:54Z |
format | Article |
id | doaj.art-ff1c355ae1cd48c6a0bb24435c497fa0 |
institution | Directory Open Access Journal |
issn | 1080-6040 1080-6059 |
language | English |
last_indexed | 2024-04-12T15:03:54Z |
publishDate | 2022-06-01 |
publisher | Centers for Disease Control and Prevention |
record_format | Article |
series | Emerging Infectious Diseases |
spelling | doaj.art-ff1c355ae1cd48c6a0bb24435c497fa02022-12-22T03:28:00ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592022-06-012861274127510.3201/eid2806.220503Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster VaccinationRune M. PedersenLine L. BangLone W. MadsenThomas V. SydenhamIsik S. JohansenThøger G. JensenUlrik S. JustesenThomas E. Andersen The SARS-CoV-2 Omicron variant BA.2 sublineage is rapidly replacing earlier Omicron lineages, suggesting BA.2 has increased vaccine evasion properties. We measured neutralization titers of authentic BA.1 and BA.2 isolates in serum samples from persons who received the BNT162b2 booster vaccine. All samples neutralized BA.1 and BA.2 at equal median values. https://wwwnc.cdc.gov/eid/article/28/6/22-0503_articleCOVID-19respiratory infectionssevere acute respiratory syndrome coronavirus 2SARS-CoV-2SARScoronavirus disease |
spellingShingle | Rune M. Pedersen Line L. Bang Lone W. Madsen Thomas V. Sydenham Isik S. Johansen Thøger G. Jensen Ulrik S. Justesen Thomas E. Andersen Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination Emerging Infectious Diseases COVID-19 respiratory infections severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 SARS coronavirus disease |
title | Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination |
title_full | Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination |
title_fullStr | Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination |
title_full_unstemmed | Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination |
title_short | Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination |
title_sort | serum neutralization of sars cov 2 omicron ba 1 and ba 2 after bnt162b2 booster vaccination |
topic | COVID-19 respiratory infections severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 SARS coronavirus disease |
url | https://wwwnc.cdc.gov/eid/article/28/6/22-0503_article |
work_keys_str_mv | AT runempedersen serumneutralizationofsarscov2omicronba1andba2afterbnt162b2boostervaccination AT linelbang serumneutralizationofsarscov2omicronba1andba2afterbnt162b2boostervaccination AT lonewmadsen serumneutralizationofsarscov2omicronba1andba2afterbnt162b2boostervaccination AT thomasvsydenham serumneutralizationofsarscov2omicronba1andba2afterbnt162b2boostervaccination AT isiksjohansen serumneutralizationofsarscov2omicronba1andba2afterbnt162b2boostervaccination AT thøgergjensen serumneutralizationofsarscov2omicronba1andba2afterbnt162b2boostervaccination AT ulriksjustesen serumneutralizationofsarscov2omicronba1andba2afterbnt162b2boostervaccination AT thomaseandersen serumneutralizationofsarscov2omicronba1andba2afterbnt162b2boostervaccination |